Linkage of left ventricular contractility to chromosome 11 in humans: The hyperGEN study

Hypertension

Volumn 38, Issue 4, 2001, Pages 767-772

  Arnett, Donna K ^a   Devereux, Richard B ^a   Kitzman, Dalane ^a   Oberman, Al ^a   Hopkins, Paul ^a   Atwood, Larry ^a   Dewan, Andrew ^a   Rao, D C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Gene expression; Genes; Genetic; Hypertension; Myocardium; Race

Indexed keywords

MYOSIN BINDING PROTEIN C;

ADULT; ARTICLE; CAUSE OF DEATH; CHROMOSOME 11; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; FEMALE; GENDER; GENE EXPRESSION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEART LEFT VENTRICLE CONTRACTILITY; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; ONSET AGE; PRIORITY JOURNAL; RACE;

EID: 0035726972     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy1001.092650     Document Type: Article

References (33)

1. Midwall left ventricular mechanics: An independent predictor of cardiovascular risk in arterial hypertension
2. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy
3. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy
4. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy
5. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy
6. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice
7. NHLBI Family Blood Pressure Program: Methodology and recruitment in the HyperGEN Network
8. Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy: Overestimation of fiber velocities by conventional midwall measurements
9. Left ventricular midwall mechanics in systemic arterial hypertension: Myocardial function is depressed in pressure-overload hypertrophy
10. Assessment of left ventricular function by the mid-wall fractional shortening-end-systolic stress relation in human hypertension
11. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy
12. Reliability of echocardiographic assessment of left ventricular structure and function: The PRESERVE study
13. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function
14. Evaluation of cardiac function and vascular structure and function by echocardiography and other noninvasive techniques
15. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
16. Recommendations for quantification of the left ventricle by two-dimensional echocardiography
17. Prognostic significance of regional wall motion abnormality in patients with prior myocardial infarction: A prospective correlative study of two-dimensional echocardiography and angiography
18. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy
19. Exact multipoint quantitative-trait linkage analysis in pedigrees by variance components
20. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
21. Independent genetic susceptibility to cardiac hypertrophy in inherited hypertension
22. Quantitative genetics of relative organ weight variation in captive baboons
23. Heritability of left ventricular mass. The Framingham heart study
24. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension
25. Cellular and molecular aspects of contractile dysfunction in heart failure
26. Cardiac hypertrophy, arrhythmogenicity and the new myocardial phenotype, II: The cellular adaptational process
27. Familial hypertrophic cardiomyopathy: A paradigm of the cardiac hypertrophic response to injury
28. Familial hypertrophic cardiomyopathy: From mutations to functional defects
29. Molecular genetic studies of familial hypertrophic cardiomyopathy
30. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy
31. Genetic linkage analyses for left ventricular mass phenotypes in the Framingham heart study
32. Beta-adrenergic mechanisms in cardiac diseases: A perspective